アフターアワーズ： 430.8833 0.9533 +0.22%

Vertex Pharmaceuticals, Inc. (VRTX)

Vertex Pharmaceuticals, Inc. (VRTX) 最新ニュース

Vertex Pharmaceuticals, Inc. (VRTX)

Vertex Pharmaceuticals, Inc. (VRTX) 最新ニュース

Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy

2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade

bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well

Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down

CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss

Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip

Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales

Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript

Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates

CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?

3 No-Brainer Stocks to Buy in May

Wall Street Breakfast: The Week Ahead

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know

Unveiling Vertex (VRTX) Q1 Outlook: Wall Street Estimates for Key Metrics

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

2 Top Growth Stocks to Buy Right Now and Hold Forever

Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.

The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals

Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know

Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX

2 Fantastic Growth Stocks to Buy Right Now

Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies

Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?

Making Sense of Amazon CEO Andy Jassy's Latest Letter

If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today

Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now

2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever

3 Relatively Safe Growth Stocks You Can Buy and Hold

Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug

Is Vertex Pharmaceuticals Stock a Millionaire Maker?

Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday

Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

bluebird (BLUE) Underperforms Industry YTD Amid Challenges

Is Vertex (VRTX) a Buy as Wall Street Analysts Look Optimistic?

Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock

Should You Invest in the VanEck Biotech ETF (BBH)?

Could This Stock Be the Next Biotech Buyout?

The Analyst Landscape: 16 Takes On Vertex Pharmaceuticals

Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact

Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?

Vertex Pharmaceuticals: Buy, Sell, or Hold?

Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note

VRTXに似た銘柄